3 Wall Street Analysts Have Oracle Going to $400: An Alphabet Partnership Just Jump Started That 200% Upside

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • Three analysts at Guggenheim, Jefferies, and Global Equities Research target ORCL at $400, implying 214% upside from a stock down 49% over the past year on balance-sheet fears, not operational weakness.

  • GOOGL's Gemini integration into Oracle Cloud Infrastructure sent ORCL shares up 6%, joining Meta, OpenAI, and xAI as OCI model partners.

  • Oracle's $638 billion RPO surged 363% year-over-year, giving 37 of 43 analysts Buy-or-better conviction while a forward P/E of 15 sits well below the S&P 500 average.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Oracle didn't make the cut. Grab the names FREE today.

3 Wall Street Analysts Have Oracle Going to $400: An Alphabet Partnership Just Jump Started That 200% Upside

© maywong_photos / Flickr

Oracle (NYSE:ORCL | ORCL Price Prediction) currently trades at $127.56 against a consensus analyst target of $248.15, implying roughly 95% upside.

Beyond that consensus, a $400 Street-high target sits at three desks led by John DiFucci at Guggenheim, along with Jefferies and Global Equities Research. That is the “200% upside” call the headline is built on. Oracle sells cloud infrastructure, databases, and enterprise applications, and has spent the past year rebuilding itself into one of the biggest AI infrastructure stories on Wall Street. The gap matters because Oracle just announced an expanded partnership with Alphabet, integrating Google’s Gemini models across Oracle Cloud Infrastructure and Fusion Applications. Shares jumped over 6% on the news.

What Sparked Oracle’s Historic Cloud-Era Selloff

Oracle has cratered 48.52% over one year, with a peak-to-trough drawdown exceeding 60%. The cause is balance-sheet fear, not operational weakness. S&P Global cut Oracle’s credit rating from BBB to BBB-, one notch above junk, citing debt from the AI infrastructure buildout.

Oracle then laid off about 21,000 employees, roughly 13% of its workforce, to help fund a $300 billion AI computing contract with OpenAI. Management also announced a $260 billion AI leasing plan, and S&P projects a $42 billion free cash flow deficit for fiscal 2027. FY2026 free cash flow already ran at -$23.7 billion on $55.7 billion of capex.

Why 43 Analysts Are Still Pounding the Table

One number explains the analyst stance. Oracle’s Remaining Performance Obligations hit $638 billion in Q4 FY2026, up 363% year over year, growing from $455 billion in Q1 in just four quarters. That backlog is signed, contracted cloud revenue waiting to convert.

Oracle Cloud Infrastructure grew 93% YoY to $5.79 billion in Q4, accelerating every quarter of FY2026. The multicloud database strategy embeds OCI inside Microsoft Azure, Google Cloud, and AWS data centers, capturing enterprise spend without a head-on cloud-footprint fight. And $75 billion of the RPO is tied to prepaid or customer-supplied GPU arrangements, which eases Oracle’s own capex burden.

The Gemini partnership adds Google to an OCI model lineup that already includes Meta, OpenAI, and xAI. Oracle also raised FY2027 non-GAAP EPS guidance to $8.05 and confirmed $90 billion in revenue, with Q1 FY2027 cloud revenue guided to grow 58% to 64%. Of 43 covering analysts, 8 rate it Strong Buy, 29 Buy, 5 Hold, and 1 Sell. Recent moves have been reiterations. Mizuho reaffirmed Outperform at $320 in June.

Cloud Rivals Have Not Cratered Like This

Oracle fell alone. The rest of the hyperscaler cohort held up while the S&P 500 climbed 8.76%.

Alphabet (NASDAQ:GOOGL) trades at $333.66 against a $427.59 target, roughly 28% upside. Google Cloud grew 82% YoY to $24.77 billion last quarter, with analyst posture skewing heavily Buy.

Microsoft (NASDAQ:MSFT) sits at $528.09 versus a $650 consensus target, about 23% upside. Azure remains the primary AI cloud beneficiary with 54 of 57 analysts rating it Buy or better.

Amazon (NASDAQ:AMZN) trades at $232.79 against a $310 consensus target, roughly 33% upside. AWS is the largest hyperscaler with an overwhelmingly Buy analyst book.

Oracle offers the largest implied upside in the group by a wide margin. No peer offers anything close to Oracle’s spread against either the $248 consensus or the $400 Street-high.

The Numbers Behind the $400 Case

Oracle trades at $127.56. Consensus target is $248.15 (about 95% upside), with a Street-high of $400 implying roughly 214% upside. Forward P/E is 15, meaningfully below the S&P 500 average.

Year to date, Oracle is down 33.92% while the S&P 500 has gained 8.76%. That is more than 40 percentage points of relative underperformance in seven months. Coverage is deep: 37 of 43 analysts are Buy-or-better, and the target spread signals unusual disagreement about where the AI infrastructure trade ultimately settles.

My Take on Oracle Below $130

The bull case holds if the $638 billion RPO converts on schedule and the multicloud plus Gemini strategy sustains 50%-plus cloud revenue growth into FY2028. That is the direct path to $248 consensus, and if margins hold at the FY2027 EPS guide of $8.05, the $400 Street-high stops looking like fantasy.

The bear case takes over if free cash flow remains deeply negative through FY2028 and the credit rating slips into junk. A BBB- rating on $218.7 billion in total liabilities and a projected $42 billion FCF deficit is the value-trap risk. If OpenAI or another anchor customer renegotiates, the RPO figure gets uglier fast.

I lean cautiously bullish. The operational data is too strong to ignore, the Gemini partnership provides a real catalyst, and the market has already priced heavy execution risk into a stock cut roughly in half over the past year. From here, even a modest re-rating closes a large piece of the gap.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

NDSN Vol: 1,255,654
COIN Vol: 17,498,357
DE Vol: 3,199,877
CF Vol: 3,314,818
MOS Vol: 12,617,712

Top Losing Stocks

MRNA Vol: 99,349,960
WMT Vol: 83,569,321
CTRA Vol: 73,319,495
ISRG Vol: 3,969,495
CRWD Vol: 8,864,505